Famous Biotech Billionaire Purchases $26.5 Million Worth of IOVA – Insider Weekends

Key Insights

• Famous biotechnology investor Wayne P. Rothbaum purchased $26.5 million worth of a clinical-stage biotechnology company, Iovance Biotherapeutics Inc. (IOVA).
• Mr. Rothbaum is well known for his investments in companies such as Acerta Pharma, which developed the blood cancer drug Calquence, which was later sold to Astra Zeneca for over $7 billion.
• Iovance Biotherapeutics primarily develops drugs that combat cancer via investigational tumor-infiltrating lymphocytes (TIL) therapy, and is currently seeking approval for their drug lifileucel – which uses TIL therapy to fight melanoma.

Please subscribe for free or login to your InsideArbitrage account to access this article.